[{"id":"7b14f018-6d47-43a0-9577-e12c91f91d9f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06357923","created_at":"2024-04-10T13:41:56.543Z","updated_at":"2024-07-02T16:35:10.368Z","phase":"","brief_title":"Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age","source_id_and_acronym":"NCT06357923","lead_sponsor":"Centre Hospitalier Universitaire de Nice","biomarkers":" LAMP2","pipe":"","alterations":" ","tags":["LAMP2"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 05/01/2024","start_date":" 05/01/2024","primary_txt":" Primary completion: 05/02/2024","primary_completion_date":" 05/02/2024","study_txt":" Completion: 05/01/2026","study_completion_date":" 05/01/2026","last_update_posted":"2024-04-10"},{"id":"0797783e-69b0-44d9-b3a6-e57546649ab7","acronym":"","url":"https://clinicaltrials.gov/study/NCT06036355","created_at":"2023-09-13T14:10:12.423Z","updated_at":"2024-07-02T16:35:37.194Z","phase":"Phase 1","brief_title":"The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)","source_id_and_acronym":"NCT06036355","lead_sponsor":"Shanghai Cell Therapy Group Co.,Ltd","biomarkers":" PD-1 • IL6 • LAG3 • HAVCR2 • IL10 • IL4 • LAMP2","pipe":"","alterations":" ","tags":["PD-1 • IL6 • LAG3 • HAVCR2 • IL10 • IL4 • LAMP2"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 09/30/2023","start_date":" 09/30/2023","primary_txt":" Primary completion: 04/30/2024","primary_completion_date":" 04/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2023-09-13"},{"id":"9d619db8-bfbd-425a-9013-7adf11066eef","acronym":"ERASE","url":"https://clinicaltrials.gov/study/NCT03203460","created_at":"2021-01-18T15:47:44.472Z","updated_at":"2024-07-02T16:36:12.214Z","phase":"Phase 2","brief_title":"Exercise During Active Surveillance for Prostate Cancer","source_id_and_acronym":"NCT03203460 - ERASE","lead_sponsor":"University of Alberta","biomarkers":" CD20 • CD8 • IFNG • IL6 • TNFA • IL2RA • IL2 • NCAM1 • IL10 • IL1B • CRP • LAMP2","pipe":"","alterations":" ","tags":["CD20 • CD8 • IFNG • IL6 • TNFA • IL2RA • IL2 • NCAM1 • IL10 • IL1B • CRP • LAMP2"],"overall_status":"Completed","enrollment":" Enrollment 52","initiation":"Initiation: 07/01/2018","start_date":" 07/01/2018","primary_txt":" Primary completion: 05/31/2020","primary_completion_date":" 05/31/2020","study_txt":" Completion: 05/31/2021","study_completion_date":" 05/31/2021","last_update_posted":"2022-04-18"},{"id":"ae26fda2-139e-44f8-8b12-c0477efd0549","acronym":"OpACIN","url":"https://clinicaltrials.gov/study/NCT02437279","created_at":"2021-01-18T11:40:23.259Z","updated_at":"2025-02-25T14:35:35.177Z","phase":"Phase 1","brief_title":"Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients","source_id_and_acronym":"NCT02437279 - OpACIN","lead_sponsor":"The Netherlands Cancer Institute","biomarkers":" PD-L1 • TMB • PD-1 • LAMP2","pipe":"","alterations":" ","tags":["PD-L1 • TMB • PD-1 • LAMP2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • Yervoy (ipilimumab)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 11/24/2016","start_date":" 11/24/2016","primary_txt":" Primary completion: 06/28/2018","primary_completion_date":" 06/28/2018","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2022-04-15"},{"id":"5ff22ee6-6c95-4b3e-80e2-eb69bcdf6c52","acronym":"","url":"https://clinicaltrials.gov/study/NCT01199562","created_at":"2021-01-18T04:48:21.624Z","updated_at":"2025-02-25T16:23:31.204Z","phase":"","brief_title":"Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant","source_id_and_acronym":"NCT01199562","lead_sponsor":"City of Hope Medical Center","biomarkers":" NCAM1 • LAMP2","pipe":"","alterations":" ","tags":["NCAM1 • LAMP2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Valcyte (valganciclovir)"],"overall_status":"Completed","enrollment":" Enrollment 153","initiation":"Initiation: 12/01/2010","start_date":" 12/01/2010","primary_txt":" Primary completion: 12/01/2013","primary_completion_date":" 12/01/2013","study_txt":" Completion: 12/01/2013","study_completion_date":" 12/01/2013","last_update_posted":"2019-04-25"}]